Results 31 to 40 of about 174 (67)

Age‐Specific Clinical Biomarker Ranges in Acute Head Injury, Non‐TBI Trauma, and Healthy Control Subjects in the Emergency Department

Academic Emergency Medicine, Volume 33, Issue 4, April 2026.
ABSTRACT Objectives Blood‐based biomarkers for traumatic brain injury (TBI) are increasingly integrated into diagnostic algorithms, but their interpretation may be confounded by age‐related neurological changes. This study quantified the relative effects of age and TBI on biomarker concentrations to determine whether age‐related variation approaches or
Katherine D. Mayes, Timothy E. Van Meter, Nazanin Mirshahi, Sally Boyd, Danielle Sandsmark, Katya Rascovsky, Ramon Diaz‐Arrastia, Justin Weppner, W. Frank Peacock, Damon R. Kuehl, the HeadSMART II Investigators   +10 more
wiley   +1 more source

Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT‐MI

ESC Heart Failure, Volume 12, Issue 6, Page 3940-3952, December 2025.
Impact of empagliflozin in patients with and without T2D or CKD in the EMPACT‐MI trial. Baseline characteristics, HF outcomes and subgroup analysis of efficacy endpoints are shown. # Hazard ratios estimated via Cox proportional hazard model (unless indicated otherwise). ^ Rate ratios via negative binomial regression.
Francesco Fioretti, Javed Butler, Jacob A. Udell, W. Schuyler Jones, Mark C. Petrie, Josephine Harrington, Michaela Mattheus, Johann Bauersachs, Antoni Bayes‐Genis, Shaun G. Goodman, Tomasz Gasior, James L. Januzzi, Renato D. Lopes, Piotr Ponikowski, Xavier Rossello, Morten Schou, Peter van der Meer, Dragos Vinereanu, Shelley Zieroth, Martina Brueckmann, Mikhail Sumin, Deepak L. Bhatt, Adrian F. Hernandez, Stefan D. Anker   +23 more
wiley   +1 more source

Alteration of medical therapy in patients with heart failure relative to change in symptom severity

ESC Heart Failure, Volume 6, Issue 5, Page 1085-1087, October 2019., 2019
Abstract In this observational analysis from the Practice Innovation and Clinical Excellence Registry®, we examined changes in guideline‐directed medical therapies relative to changes in symptom severity in ambulatory patients with heart failure with reduced ejection fraction, finding change in medication more often occurring when patients were ...
Nasrien E. Ibrahim, Yang Song, Christopher P. Cannon, Gheorghe Doros, Patricia Russo, Angelo Ponirakis, Claire Alexanian, James L. Januzzi Jr   +7 more
wiley   +1 more source

Effect of host‐protein test (TRAIL/IP‐10/CRP) on antibiotic prescription and emergency department or urgent care center return visits: The JUNO pilot randomized controlled trial

Academic Emergency Medicine, Volume 32, Issue 9, Page 975-984, September 2025.
Abstract Objectives Determining etiology for adults with symptoms of lower respiratory tract infection (LRTI) is challenging. MeMed BV (MMBV), an FDA‐cleared blood test, computationally integrates the levels of three host proteins to differentiate bacterial and viral infections.
Adam J. Singer, Judd E. Hollander, Efrat R. Kean, Hope Ring, W. Frank Peacock, Karina M. Soto‐Ruiz, Sergey Motov, Joby Thoppil, Phyllis Hendry, Salim Halabi, Andrew C. Meltzer, Gary F. Headden, Tal Brosh‐Nissimov, David Zeltser, Chad M. Cannon   +14 more
wiley   +1 more source

Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre‐specified analysis of the EMPACT‐MI trial

European Journal of Heart Failure, Volume 27, Issue 3, Page 577-588, March 2025.
Glycaemic status and diabetes in EMPACT‐MI. HF, heart failure; LVEF, left ventricular ejection fraction; MI, myocardial infarction. Abstract Aims In the EMPACT‐MI trial, empagliflozin reduced heart failure (HF) hospitalizations but not mortality in acute myocardial infarction (MI).
Mark C. Petrie, Jacob A. Udell, Stefan D. Anker, Josephine Harrington, W. Schuyler Jones, Michaela Mattheus, Tomasz Gasior, Peter van der Meer, Offer Amir, M. Cecilia Bahit, Johann Bauersachs, Antoni Bayes‐Genis, Vijay K. Chopra, James L. Januzzi, Renato D. Lopes, Piotr Ponikowski, Xavier Rossello, Morten Schou, Shelley Zieroth, Martina Brueckmann, Mikhail Sumin, Deepak L. Bhatt, Adrian F. Hernandez, Javed Butler   +23 more
wiley   +1 more source

Barriers and facilitators to implementation of intravenous cardiovascular treatments in ambulatory settings

ESC Heart Failure, Volume 12, Issue 1, Page 695-700, February 2025.
Multi‐level barriers and facilitators to implementing ambulatory intravenous (IV) therapies. Abstract Aims Intravenous (IV) therapies have transformed the management of various cardiovascular conditions in ambulatory patients. However, uptake of these therapies in ambulatory care settings has several barriers.
Mohamed B. Jalloh, Ian Osoro, James L. Januzzi, Alka Shaunik, M. Cecilia Bahit, Serge Korjian, C. Michael Gibson, Harriette G.C. Van Spall   +7 more
wiley   +1 more source

Les mutacions del concepte de corrupció. De l'ambigüitat de les societats arcaiques a la complexitat en l'època de l'Estat regulador i de la societat del risc

Revista de Llengua i Dret - Journal of Language and Law, 2008
L'estudi observa que el concepte de corrupció ha sofert al llarg de la història unes mutacions importants. En un arc temporal de 5.000 anys l'ambigüitat de paraules com ara feqa, ta-tu, shohadh, do-ron o munus -que podien indicar alhora regal o suborn ...
Endrius Eliseo Cocciolo
doaj  

KONFERENCIA

Köz-gazdaság, 2020
BAJI PETRA–ÉRSEK KATALIN–GULÁCSI L. ÁDÁM–HUNYADI EDIT PREVENCIÓ ÉS EGÉSZSÉGES ÉLETMÓD – KEVESEBB EGÉSZSÉGÜGYI KIADÁS?    
Köz- gazdaság
doaj  

TÖRZS ÉS ALSÓ VÉGTAG STABILITÁSÁNAK VIZSGÁLATA LABDAJÁTÉKOSOK KÖRÉBEN

Stadium, 2020
A különböző labdajátékok technikai hátterét az alsó végtag szempontjából a törzs és végtag izmainak összehangolt működése biztosítja. A felületes és mély hasizmok aktivitása a mozgó (rúgó, ugró végtag), valamint a támaszkodó végtag gyorsító, fékező és ...
Kitti Lepp, Zsuzsanna Némethné Gyurcsik   +1 more
doaj   +1 more source

MicroRNAs are associated with cardiac biomarkers, cardiac structure and function and incident outcomes in heart failure

ESC Heart Failure, Volume 11, Issue 3, Page 1400-1410, June 2024.
Abstract Aims The association between microRNAs (miRNAs) and established cardiac biomarkers is largely unknown. We aimed to measure the association between plasma miRNAs and N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP), cardiac troponin I, soluble urokinase‐type plasminogen activator receptor (suPAR), and galectin‐3 with cardiac structure and ...
Aferdita Spahillari, Laurel Jackson, Dimitrios Varrias, Sam A. Michelhaugh, James L. Januzzi, Bobby Shahideh, David Daghfal, Nedyalka Valkov, Gillian Murtagh, Saumya Das   +9 more
wiley   +1 more source